Estimates Revisions Pasithea Therapeutics Corp.

Stocks

Market Closed - Nasdaq 23:00:00 08/09/2026 +03			5-day change	1st Jan Change
0.5990 ^USD	+3.28%		+6.39%	-53.57%

08-14	Pasithea Therapeutics Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
06-30	Pasithea Therapeutics Reports Positive Interim Phase 1 Advanced Cancer Study Data And Protocol Expansion	CI

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	1y. Revenue rev.	1y. EPS revision
	WUXI APPTEC CO., LTD.
	ARGENX SE
	INSMED INCORPORATED
	BIONTECH SE
	WUXI BIOLOGICS (CAYMAN) INC.
	GENMAB A/S
	PHARMAESSENTIA CORPORATION
	SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
	EXELIXIS, INC.
	Average
	Weighted average by Cap.